Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence

Highlights • The standardized incidence rate (ESR) of SGPA is 4.2–4.9 per 100,000 person years. • Women show a higher, increasing incidence and bimodal age distribution of SGPA. • The 20-year recurrence rate was 6.7%. Secondary malignant transformation 0.15%. • Positive or uncertain margins and lowe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oral oncology 2017-03, Vol.66, p.93-99
Hauptverfasser:	Valstar, M.H, de Ridder, M, van den Broek, E.C, Stuiver, M.M, van Dijk, B.A.C, van Velthuysen, M.L.F, Balm, A.J.M, Smeele, L.E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma, Pleomorphic - epidemiology Adolescent Adult Aged Carcinoma ex pleomorphic adenoma Child Child, Preschool Epidemiology Female Head and neck neoplasms Hematology, Oncology and Palliative Medicine Hormone Humans Incidence Infant Infant, Newborn Male Malignant transformation Middle Aged Neoplasm Recurrence, Local Netherlands - epidemiology Otolaryngology Pleomorphic adenoma Recurrence Risk factor Risk Factors Salivary Gland Neoplasms - epidemiology Salivary glands Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • The standardized incidence rate (ESR) of SGPA is 4.2–4.9 per 100,000 person years. • Women show a higher, increasing incidence and bimodal age distribution of SGPA. • The 20-year recurrence rate was 6.7%. Secondary malignant transformation 0.15%. • Positive or uncertain margins and lower age showed a higher odds of recurrence. • Tumors situated in the minor glands had a lower odds of recurrence.
ISSN:	1368-8375 1879-0593
DOI:	10.1016/j.oraloncology.2017.01.004